Bio-thera Solutions, Ltd. Class ASSE: 688177

Announcement on Obtaining Drug Registration Certificate for ICHALIG®/XICHALIG® (Ustekinumab Injection)

· Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for ICHALIG®/XICHALIG® (Ustekinumab Injection)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Bio-thera Solutions, Ltd. Class A

All Bio-thera Solutions, Ltd. Class A news releases